D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells
Kathrin Hammon(University Hospital Regensburg), Marina Kreutz(University Hospital Regensburg)
Cited by 13
Related Papers
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
|Frontiers in Immunology|2017|367
New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells
|PLoS ONE|2013|118
D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells
|International Journal of Molecular Sciences|2019|27
LDHB Overexpression Can Partially Overcome T Cell Inhibition by Lactic Acid
|International Journal of Molecular Sciences|2022|27
Physiological levels of 25‐hydroxyvitamin D<sub>3</sub> induce a suppressive CD4<sup>+</sup> T cell phenotype not reflected in the epigenetic landscape
|Scandinavian Journal of Immunology|2022|7